日本細胞株開発市場規模、シェア、競争環境、トレンド分析レポート:製品およびサービス別(試薬およびメディア、機器、自動化システム、遠心分離機、バイオリアクター、保存装置、その他、アクセサリーおよび消耗品、サービス)、 供給源別(哺乳類細胞株、非哺乳類細胞株)、細胞株のタイプ別(組み換え細胞株、ハイブリドーマ、連続細胞株、初代細胞株)、用途別(バイオ生産、創薬、毒性試験、組織工学、研究):2024年から2032年までの機会分析および業界予測
レポートID : ROJP1224374 | 発行日 : 2024年12月 | フォーマット : : :
1 : INTRODUCTION
1.1.1. Report Description
1.1.2. Key Benefits for Stakeholders
1.1.3. Target Audience
1.1.4. Report Scope
2 : EXECUTIVE SUMMARY
2.1. Japan Cell Line Development Market Snapshot
2.1.1. Japan Cell Line Development Market, 2019 – 2032 (USD Million)
3 : JAPAN CELL LINE DEVELOPMENT MARKET – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers
3.2.1. Advancements in Gene Editing Technologies Propel the Growth of the Market
3.2.2. Driving Factor 2 Analysis
3.3. Market Restraints
3.3.1. High Cost and Complexity of Cell Line Development May Impede the Growth of the Market
3.4. Market Opportunities
3.4.1. Government Support and Strategic Collaborations Drive the Growth of the Market
3.5. Porter’s Five Forces Analysis
4 : ANALYSIS COMPETITIVE LANDSCAPE
4.1. Company Market Share Analysis – 2023
4.1.1. Japan Cell Line Development Market: Company Market Share, by Volume, 2023
4.1.2. Japan Cell Line Development Market: Company Market Share, by Revenue, 2023
4.1.3. Japan Cell Line Development Market: Top 6 Company Market Share, by Revenue, 2023
4.1.4. Japan Cell Line Development Market: Top 3 Company Market Share, by Revenue, 2023
4.2. Japan Cell Line Development Market Company Revenue Market Share, 2023
4.3. Company Assessment Metrics, 2023
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Start-ups /SMEs Assessment Metrics, 2023
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Developments
4.5.1. Acquisitions & Mergers
4.6. Key Players Product Matrix
5 : PESTEL & ADJACENT MARKET ANALYSIS
5.1. PESTEL
5.1.1. Political Factors
5.1.2. Economic Factors
5.1.3. Social Factors
5.1.4. Technological Factors
5.1.5. Environmental Factors
5.1.6. Legal Factors
5.2. Adjacent Market Analysis
6 : JAPAN CELL LINE DEVELOPMENT MARKET – BY PRODUCTS AND SERVICES SEGMENT ANALYSIS
6.1. Japan Cell Line Development Market Overview, by Products and Services Segment
6.1.1. Japan Cell Line Development Market Revenue Share, By Products and Services, 2023 & 2032
6.1.2. Japan Cell Line Development Market Attractiveness Analysis, By Products and Services
6.1.3. Incremental Revenue Growth Opportunity, by Products and Services, 2023 – 203
6.1.4. Japan Cell Line Development Market Revenue, By Products and Services, 2019, 2023, 2027 & 2032
6.2. Reagents and Media
6.3. Equipment
6.3.1. Automated Systems
6.3.2. Centrifuges
6.3.3. Bioreactors
6.3.4. Storage equipment
6.3.5. Others
6.4. Accessories and consumables
6.5. Services
7 : JAPAN CELL LINE DEVELOPMENT MARKET – BY SOURCE SEGMENT ANALYSIS
7.1. Japan Cell Line Development Market Overview, by Source Segment
7.1.1. Japan Cell Line Development Market Revenue Share, By Source, 2023 & 2032
7.1.2. Japan Cell Line Development Market Attractiveness Analysis, By Source
7.1.3. Incremental Revenue Growth Opportunity, by Source, 2023 – 2032
7.1.4. Japan Cell Line Development Market Revenue, By Source, 2019, 2023, 2027 & 2032
7.2. Mammalian cell line
7.3. Non-mammalian cell line
7.3.1. Insects
7.3.2. Amphibians
8 : JAPAN CELL LINE DEVELOPMENT MARKET – BY TYPE OF CELL LINE SEGMENT ANALYSIS
8.1. Japan Cell Line Development Market Overview, by Type of Cell Line Segment
8.1.1. Japan Cell Line Development Market Revenue Share, By Type of Cell Line, 2023 & 2032
8.1.2. Japan Cell Line Development Market Attractiveness Analysis, By Type of Cell Line
8.1.3. Incremental Revenue Growth Opportunity, by Type of Cell Line, 2023 – 2032 52
8.1.4. Japan Cell Line Development Market Revenue, By Type of Cell Line, 2019, 2023, 2027 & 2032 53
8.2. Recombinant cell lines
8.3. Hybridomas
8.4. Continuous cell lines
8.5. Primary cell lines
9 : JAPAN CELL LINE DEVELOPMENT MARKET – BY APPLICATION SEGMENT ANALYSIS
9.1. Japan Cell Line Development Market Overview, by Application Segment
9.1.1. Japan Cell Line Development Market Revenue Share, By Application, 2023 & 2032
9.1.2. Japan Cell Line Development Market Attractiveness Analysis, By Application
9.1.3. Incremental Revenue Growth Opportunity, by Application, 2023 – 2032
9.1.4. Japan Cell Line Development Market Revenue, By Application, 2019, 2023, 2027 & 2032
9.2. Bioproduction
9.3. Drug Discovery
9.4. Toxicity Testing
9.5. Tissue Engineering
9.6. Primary cell lines
10 : COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. Swot Analysis
10.1.4. Business Strategy
10.1.5. Financial Overview
10.2. Danaher
10.3. Sartorius AG
10.4. Merck KGaACorning Inc.
10.5. Lonza
10.6. WuXi PharmaTech
10.7. Advanced Instruments
10.8. Berkeley Lights
11 : RESEARCH METHODOLOGY
11.1. Research Methodology
11.1.1. Phase I – Secondary Research
11.1.2. Phase II – Data Modeling
11.1.3. Phase III – Primary Research
11.1.4. Research Limitations